CONNECT WITH US
AI & Deeptech

AI & Deeptech

Broadening access to AI for scientists

OpenAI logo

Published on

Add as a preferred source on Google
Broadening access to AI for scientists

We’re expanding the ChatGPT for Academic Researchers program to give up to 200,000 researchers worldwide free access to ChatGPT.

The program began as a pilot in July. Applications for the next round open Monday, November 23. We’ll award 50,000 new grants to eligible researchers on a first-come, first-served basis. Each grant gives the recipient and up to two collaborators free access to ChatGPT Plus. If you’re already on the waitlist and qualify, we’ll email you before applications open with instructions for activating your account.

Participants can use OpenAI’s frontier models and get training on how to use ChatGPT in their research. By default, we don’t use data shared through the program to train our models.

Waitlist signups by country or territory as of November 12, 2026. Darker colors indicate more signups on a logarithmic scale.

20,000 researchers in 33 countries have joined the program since the pilot began in July. Shuqi Li, a researcher at Brigham and Women’s Hospital and Harvard Medical School, looks for new drug targets that could ultimately shorten tuberculosis treatment. He is exploring whether ChatGPT can help link lab and patient data to speed up antibiotic development. Arthur Porto, assistant curator of AI biodiversity at the Florida Museum of Natural History, and his team uses AI tools to turn photographs of museum specimens into searchable databases. They also created a 3D model of a butterfly whose wings change color as you turn it, just like the real specimen.

We’re also publishing Science at the Frontier: How Scientists Use ChatGPT , new research from our Economic Research team examining how more than 1,800 researchers used ChatGPT during the program’s summer pilot.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.